HKD 0.17
(27.48%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 35.89 Million HKD | -78.73% |
2022 | 28.09 Million HKD | 6.67% |
2021 | 72.01 Million HKD | 135.49% |
2020 | 18.18 Million HKD | 27.93% |
2019 | 22.19 Million HKD | 4918.95% |
2018 | -1.78 Million HKD | -104.3% |
2017 | 11.54 Million HKD | 1045.37% |
2016 | -1.49 Million HKD | -103.74% |
2015 | 30.62 Million HKD | 25.99% |
2014 | 21.13 Million HKD | 6.52% |
2013 | 24.12 Million HKD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 8.66 Million HKD | 0.0% |
2024 Q2 | 8.59 Million HKD | -0.85% |
2023 Q1 | 20.17 Million HKD | 273.62% |
2023 Q2 | 30.35 Million HKD | 50.49% |
2023 FY | - HKD | -78.73% |
2022 Q1 | -959.3 Thousand HKD | -103.5% |
2022 FY | - HKD | 6.67% |
2022 Q4 | -11.61 Million HKD | -2.58% |
2022 Q3 | -11.32 Million HKD | -7.88% |
2022 Q2 | -10.49 Million HKD | -994.37% |
2021 FY | - HKD | 135.49% |
2021 Q3 | 13.18 Million HKD | -55.49% |
2021 Q4 | 27.41 Million HKD | 107.95% |
2021 Q2 | 29.62 Million HKD | 134.54% |
2021 Q1 | 12.63 Million HKD | 99.24% |
2020 FY | - HKD | 27.93% |
2020 Q3 | 791.54 Thousand HKD | -95.61% |
2020 Q4 | 6.33 Million HKD | 700.87% |
2020 Q2 | 18.01 Million HKD | 140.17% |
2020 Q1 | 7.5 Million HKD | -60.45% |
2019 Q2 | 15.57 Million HKD | 151.82% |
2019 Q1 | 6.18 Million HKD | 196.65% |
2019 FY | - HKD | 4918.95% |
2019 Q4 | 18.97 Million HKD | 246.25% |
2019 Q3 | 5.47 Million HKD | -64.82% |
2018 Q4 | -6.39 Million HKD | -81.25% |
2018 Q3 | -3.53 Million HKD | -278.36% |
2018 FY | - HKD | -104.3% |
2018 Q1 | 2.08 Million HKD | -67.16% |
2018 Q2 | 1.97 Million HKD | -5.27% |
2017 Q3 | 6.22 Million HKD | 904.32% |
2017 Q2 | 619.49 Thousand HKD | 2.03% |
2017 Q1 | 607.19 Thousand HKD | -87.69% |
2017 FY | - HKD | 1045.37% |
2017 Q4 | 6.36 Million HKD | 2.28% |
2016 Q1 | 9.83 Million HKD | 0.0% |
2016 FY | - HKD | -103.74% |
2016 Q4 | 4.93 Million HKD | -3.97% |
2016 Q2 | 9.55 Million HKD | -2.89% |
2016 Q3 | 5.13 Million HKD | -46.2% |
2015 FY | - HKD | 25.99% |
2014 FY | - HKD | 6.52% |
2013 FY | - HKD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Starlite Holdings Limited | 71.42 Million HKD | 49.743% |
Litu Holdings Limited | 1.21 Million HKD | -2861.881% |
Touyun Biotech Group Limited | -228.56 Million HKD | 115.706% |
Huaxi Holdings Company Limited | -31.47 Million HKD | 214.038% |